Biodel Company Profile (NASDAQ:BIOD)

About Biodel

Biodel logoBiodel Inc. is a specialty biopharmaceutical company. The Company focuses on the development and commercialization of treatments for diabetes. The Company is engaged in developing product candidates by applying its formulation technologies to existing drugs. The Company is engaged in developing room temperature stable glucagon presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia. It also develops insulin formulations for Type 1 and Type 2 diabetes patients. Its product pipeline includes RHI-based Ultra-Rapid-Acting Insulin, Analog-based Ultra-Rapid-Acting Insulin, Concentrated Ultra-Rapid-Acting Insulin and Glucagon. The Company's BIOD-531 is a Concentrated Ultra-Rapid-Acting Insulin and its insulin analog-based ultra-rapid-acting insulin product candidates include BIOD-123, BIOD-531, BIOD-238 and BIOD-250. It also conducts pre-clinical testing to develop liquid formulations of glucagon for hypoglycemic rescue and other indications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOD
  • CUSIP:
Key Metrics:
  • Previous Close: $0.45
  • 50 Day Moving Average: $0.4137
  • 200 Day Moving Average: $0.3731
  • 52-Week Range: $0.22 - $0.63
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.02
  • P/E Growth: 0.0000
  • Market Cap: $28.85M
  • Outstanding Shares: 64,148,000
  • Beta: 1.93
  • Return on Equity: -42.69%
  • Return on Assets: -39.77%
  • Current Ratio: 11.31%
  • Quick Ratio: 11.31%
Additional Links:
Companies Related to Biodel:

Analyst Ratings

Consensus Ratings for Biodel (NASDAQ:BIOD) (?)
Ratings Breakdown: 3 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00 (350.05% upside)

Analysts' Ratings History for Biodel (NASDAQ:BIOD)
DateFirmActionRatingPrice TargetDetails
12/18/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details
12/18/2015William BlairDowngradeOutperform -> Market PerformView Rating Details
10/14/2015WedbushReiterated RatingNeutral$2.00View Rating Details
5/18/2015Roth CapitalInitiated CoverageBuy$5.00View Rating Details
(Data available from 9/26/2014 forward)


Earnings History for Biodel (NASDAQ:BIOD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016Q216($0.05)ViewN/AView Earnings Details
5/9/2016Q2($0.04)($0.09)ViewN/AView Earnings Details
2/16/2016Q1($0.08)($0.05)ViewN/AView Earnings Details
12/17/2015Q315($0.11)($0.05)ViewListenView Earnings Details
8/13/2015Q3($0.10)($0.12)ViewListenView Earnings Details
5/6/2015Q215($0.23)($0.18)ViewN/AView Earnings Details
2/12/2015Q115($0.17)($0.20)ViewN/AView Earnings Details
12/17/2014Q414($0.25)($0.16)ViewN/AView Earnings Details
8/11/2014($0.26)($0.15)ViewN/AView Earnings Details
5/13/2014Q114($0.24)($0.29)ViewN/AView Earnings Details
2/6/2014Q4($0.19)($0.20)ViewN/AView Earnings Details
12/18/2013Q4($0.32)($0.04)ViewListenView Earnings Details
8/12/2013Q3 2013($0.37)($0.66)ViewN/AView Earnings Details
5/8/2013Q2 2013($0.43)($0.37)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Biodel (NASDAQ:BIOD)
Current Year EPS Consensus Estimate: $-0.1700 EPS
Next Year EPS Consensus Estimate: $-0.2200 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.05)($0.05)($0.05)
Q1 20171($0.05)($0.05)($0.05)
Q2 20171($0.05)($0.05)($0.05)
Q3 20171($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)


Dividend History for Biodel (NASDAQ:BIOD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Biodel (NASDAQ:BIOD)
Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 8.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/20/2013Brian Jg PereiraDirectorSell4,734$2.26$10,698.84View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Biodel (NASDAQ:BIOD)
News IconType 1 Diabetes Market estimates and forecasts, 2015 to 2021 ... - Medgadget (blog) (NASDAQ:BIOD) - September 24 at 8:05 AM
News IconKeen Investors Find News on Biodel Inc. (NASDAQ:BIOD) - Duncan Research (NASDAQ:BIOD) - September 23 at 3:18 PM
News IconUnder the Microscope, Zeroing in at Biodel Inc. (NASDAQ:BIOD) - Duncan Research (NASDAQ:BIOD) - September 22 at 4:00 PM logoBIODEL INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf (NASDAQ:BIOD) - September 22 at 8:04 AM
News IconGlobal Oral Proteins Market 2016- Biodel Inc, Biocon - cHollywood News Portal (press release) (NASDAQ:BIOD) - September 21 at 8:23 AM
News IconPenny Stock Investors Take an Interest in Biodel Inc. (NASDAQ:BIOD) - Duncan Research (NASDAQ:BIOD) - September 21 at 8:23 AM
News IconMy Watchlist for Monday, September 12 (NASDAQ:BIOD) - September 12 at 8:38 AM logoBIODEL INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NASDAQ:BIOD) - September 10 at 8:34 AM logoBIODEL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agree (NASDAQ:BIOD) - September 10 at 8:34 AM logoAlbireo Appoints Dr. Paresh N. Soni as Chief Medical Officer (NASDAQ:BIOD) - September 8 at 8:16 AM
News Icon"Hypoglycemia - Pipeline Review, H2 2016" now available at Fast Market Research (NASDAQ:BIOD) - September 1 at 3:49 PM
News IconHow Analysts & Retail Investors Perceive Biodel Inc. (NASDAQ ... - Post News (NASDAQ:BIOD) - August 23 at 5:13 AM logoBIODEL INC Financials (NASDAQ:BIOD) - August 19 at 4:32 PM logoBIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, (NASDAQ:BIOD) - August 12 at 12:28 PM logoBiodel Reports Third Quarter Fiscal Year 2016 Financial Results (NASDAQ:BIOD) - August 11 at 9:43 PM logoBIODEL INC Files SEC form 10-Q, Quarterly Report (NASDAQ:BIOD) - August 11 at 9:43 PM logoDrug Manufacturers Stocks on Investors' Radar -- Synergy Pharma, Novo Nordisk, Biodel, and DURECT (NASDAQ:BIOD) - August 4 at 12:26 PM
News IconResearch report explores the global human insulin market to surge at a CAGR of 8.1% and is projected to reach USD 39.13 billion by 2020 (NASDAQ:BIOD) - August 1 at 8:46 AM
News IconOvercoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza (NASDAQ:BIOD) - August 1 at 8:46 AM logoNoteworthy Buzzers: Community Health Systems, Inc. (NYSE:CYH) , Biodel Inc. (NASDAQ:BIOD) - Street Updates (NASDAQ:BIOD) - July 29 at 3:51 PM logoBiodel Inc. (NASDAQ:BIOD) Insider Activities Are in the Air - Review Fortune (NASDAQ:BIOD) - July 29 at 3:51 PM logoNoticeable Buzzers: Medtronic plc (NYSE:MDT) , Biodel Inc ... - Street Updates (NASDAQ:BIOD) - July 28 at 4:54 PM logoStocks Movements Activity: Tobira Therapeutics, Inc. (NASDAQ:TBRA) , Biodel Inc. (NASDAQ:BIOD) - Street Updates (NASDAQ:BIOD) - July 26 at 3:45 PM
News IconBiodel Inc. (NASDAQ:BIOD): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:BIOD) - July 21 at 9:25 PM
News IconEquity Roundup: Stock Performance Focus on Biodel Inc. (NASDAQ:BIOD) - Press Telegraph (NASDAQ:BIOD) - July 20 at 11:53 AM
News IconHow Analysts Rated Biodel Inc (NASDAQ:BIOD) Last Week? - Press Telegraph (NASDAQ:BIOD) - July 19 at 10:01 AM
News IconThomas A. Shea Joins Albireo as Chief Financial Officer (NASDAQ:BIOD) - July 18 at 8:47 AM
News IconAnalyst Target and Average Rating Watch: Biodel Inc. (NASDAQ:BIOD) - Press Telegraph (NASDAQ:BIOD) - July 14 at 3:52 PM
News IconBiodel Inc (NASDAQ:BIOD) Move Up as Institutional Investors' Sentiment Falls - Consumer Eagle (NASDAQ:BIOD) - July 14 at 3:52 PM
News IconBiodel Inc. (NASDAQ:BIOD) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:BIOD) - July 14 at 3:52 PM logoBIODEL INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NASDAQ:BIOD) - July 13 at 11:55 AM
News IconBiodel Inc. (NASDAQ:BIOD) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:BIOD) - July 12 at 5:19 AM
News IconHow Many Biodel Inc (NASDAQ:BIOD)'s Analysts Are Bearish? - Engelwood Daily (NASDAQ:BIOD) - July 10 at 8:33 AM
News IconCan Biodel Inc. (NASDAQ:BIOD) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:BIOD) - July 7 at 3:50 PM
News IconCompany Stock Focus for Biodel Inc. (NASDAQ:BIOD): Which Way Will Shares Head? - Press Telegraph (NASDAQ:BIOD) - July 7 at 11:46 AM logoBiodel Inc. (BIOD) Current Analyst Ratings - Fiscal Standard (NASDAQ:BIOD) - July 6 at 8:39 AM logoBiodel Inc. (BIOD) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BIOD) - July 4 at 3:46 PM
News IconHow Many Biodel Inc (NASDAQ:BIOD)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:BIOD) - July 3 at 8:35 AM logoPen Needles Market Forecast to Grow at 11.2% CAGR to 2021 led by Standard Needles Segment (NASDAQ:BIOD) - June 28 at 4:01 PM logoNew Broker Ratings For Biodel Inc. (BIOD) - FTSE News (NASDAQ:BIOD) - June 27 at 3:29 PM
News IconBiodel Inc. (NASDAQ:BIOD) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:BIOD) - June 23 at 11:17 PM logoRecently Issued Stock Ratings For Biodel Inc. (BIOD) - Fiscal Standard (NASDAQ:BIOD) - June 21 at 8:36 AM
News IconType 1 Diabetes Market : Size, Share, Development, Growth and Demand Forecast to 2015 – 2021 (NASDAQ:BIOD) - June 16 at 9:13 PM logoNotable Stocks within Investor Radar: Biodel Inc. (NASDAQ:BIOD) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates (NASDAQ:BIOD) - June 16 at 8:13 AM logoHave a look at Price Moves: Depomed, Inc. (NASDAQ:DEPO) , Biodel Inc. (NASDAQ:BIOD) - Street Updates (NASDAQ:BIOD) - June 15 at 3:53 PM
News IconStock Review and Earnings Check on Biodel Inc. (NASDAQ:BIOD) - HNN (NASDAQ:BIOD) - June 3 at 9:55 PM
News IconEarnings Trends of the Stock: Biodel Inc. (NASDAQ:BIOD), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Beacon Chronicle (NASDAQ:BIOD) - June 3 at 3:55 PM logoBiotech Stocks within Traders Radar: Immunomedics, Inc. (NASDAQ:IMMU) , Biodel Inc. (NASDAQ:BIOD) - Is stories (NASDAQ:BIOD) - June 3 at 12:25 PM
News IconTarget Price and Stock Performance Rundown for Biodel Inc. (NASDAQ:BIOD) - HNN (NASDAQ:BIOD) - June 1 at 12:20 PM logoLatest Analysts Tips Update: Johnson & Johnson (NYSE:JNJ) , Biodel Inc. (NASDAQ:BIOD) - Street Updates (NASDAQ:BIOD) - May 31 at 3:52 PM


Biodel (NASDAQ:BIOD) Chart for Monday, September, 26, 2016

Last Updated on 9/26/2016 by Staff